Back to search

The University of Edinburgh

Effect of stabilising mutations in β-catenin on PROTAC-mediated degradation kinetics

Abstract

dc:description.abstract

Protein degrader drugs such as PROTACs have emerged as a chemical strategy to degrade pathological proteins via recruitment to E3 ubiquitin ligase complexes. How the basal rate of target protein turnover influences PROTAC-mediated degradation is incompletely understood. To address this question, I focused on the oncogenic transcription factor β-catenin, which is activated in human cancer by a variety of stabilising mutations within a degron motif. Here, I use a synthetic degron tag system to compare the kinetics of different PROTAC degraders on β-catenin activated via oncogenic stabilising mutations of different strengths. Interestingly, even an approximately fivefold increase in stability levels resulted in similar absolute protein levels after PROTACs-mediated degradation. This finding suggests that the maximum degradation was not solely determined by protein stability. Additionally, it showed that PROTACs can override natural rates of protein turnover, even when they have been disrupted by oncogenic mutations. Understanding this could help to predict how well patients with different oncogenic mutations will respond to PROTAC therapy.

Degree

thesis:*
Grantor dc:publisher
The University of Edinburgh
Year dc:date.issued
2024

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gudauskaitė, Evelina
Advisors dc:contributor.advisor
  • Wood, Andrew
  • Boulter, Luke

Subjects

dc:subject × 7

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gudauskaitė, Evelina. Effect of stabilising mutations in β-catenin on PROTAC-mediated degradation kinetics. The University of Edinburgh, 2024. https://hdl.handle.net/1842/42384